We are committed to serving the best interests of our shareholders. The investor pages that follow are your resource for financial information about Catalyst Biosciences, Inc.
NASDAQ: CBIO$31.082.01 (6.07%)Feb 16, 20184:00 p.m. ET
Delayed at least 15 minutes
Data provided by Nasdaq. Minimum 15 minutes delayed.
Press ReleasesFebruary 15, 2018Catalyst Biosciences Announces Closing of Public Offering of Common StockFebruary 13, 2018Catalyst Biosciences Announces Pricing of Public Offering of Common StockFebruary 12, 2018Catalyst Biosciences Announces Proposed Public Offering of Common StockView all press releases »
Reverse Stock Split
|For the 1 for 15 Reverse Stock Split Tax Form, click here|
Targacept Special Dividend
|For the FAQ and additional information, click here.|
Catalyst Biosciences, Inc.
Red House Consulting, LLC